close 73% jaeinvestorite kontodest jääb selle teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. CFD-d on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti. 73% jaeinvestorite kontodest jääb selle teenusepakkuja juures CFD-dega kauplemisel kahjumisse. Palume teil kaaluda, kas CFD-de toimimine on teile arusaadav ja kas te olete valmis võtma riski, mis suure tõenäosusega on kahjumlik.
Change languageEesti
Ülevaade

LLY

1,017.74

+3%↑

JNJ

194.37

+0.29%↑

ABBV

233.26

+3.63%↑

UNH

339.07

+3.56%↑

AZN

87.67

-1.55%↓

LLY

1,017.74

+3%↑

JNJ

194.37

+0.29%↑

ABBV

233.26

+3.63%↑

UNH

339.07

+3.56%↑

AZN

87.67

-1.55%↓

LLY

1,017.74

+3%↑

JNJ

194.37

+0.29%↑

ABBV

233.26

+3.63%↑

UNH

339.07

+3.56%↑

AZN

87.67

-1.55%↓

LLY

1,017.74

+3%↑

JNJ

194.37

+0.29%↑

ABBV

233.26

+3.63%↑

UNH

339.07

+3.56%↑

AZN

87.67

-1.55%↓

LLY

1,017.74

+3%↑

JNJ

194.37

+0.29%↑

ABBV

233.26

+3.63%↑

UNH

339.07

+3.56%↑

AZN

87.67

-1.55%↓

Kodu・Aktsiate loetelu・Pulse Biosciences Inc
Search

Pulse Biosciences Inc

Suletud

SektorTervishoid

14.99 -1.45

Osta

Hinna uuendus 12. nov 2025, 20:59 UTC

OstaMüü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

14.83

Max

15.21

Põhinäitajad

By Trading Economics

Sissetulek

-217K

-19M

Müük

86K

86K

Aktsiakasum

-0.29

Kasumimarginaal

-22,540.698

Töötajad

75

EBITDA

-1.2M

-20M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+46.67% upside

Turustatistika

By TradingEconomics

Turukapital

-97M

1B

Eelmine avamishind

16.44

Eelmine sulgemishind

14.99

Uudiste sentiment

By Acuity

67%

33%

333 / 374 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

16.59 / 17.17 Toetus ja vastupanu

Pulse Biosciences Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

12. nov 2025, 21:55 UTC

Tulu

Xero Beats 1st Half Profit Expectations Despite Melio Margin Hit

DJ

Loe

12. nov 2025, 21:34 UTC

Tulu

Cisco Systems Boosts Fiscal Year Outlook as 1Q Profit, Revenue Rise

DJ

Loe

12. nov 2025, 23:44 UTC

Market Talk

Nikkei May Trade in Range Amid Caution Over U.S. Econ -- Market Talk

DJ

Loe

12. nov 2025, 23:38 UTC

Market Talk

Gold Steady Ahead of Expected End to U.S. Government Shutdown -- Market Talk

DJ

Loe

12. nov 2025, 23:13 UTC

Tulu

Samsung Fire & Marine Insurance 3Q Net Profit Largely Met FactSet-Compiled Consensus

DJ

Loe

12. nov 2025, 23:13 UTC

Tulu

Samsung Fire & Marine Insurance 3Q Net KRW538.50B Vs. Net KRW554.56B >000810.SE

DJ

Loe

12. nov 2025, 23:13 UTC

Tulu

Samsung Fire & Marine Insurance 3Q Oper Pft KRW664.06B Vs. Pft KRW717.46B >000810.SE

DJ

Loe

12. nov 2025, 23:13 UTC

Tulu

Samsung Fire & Marine Insurance 3Q Rev KRW5.732T Vs. KRW5.326T >000810.SE

DJ

Loe

12. nov 2025, 22:30 UTC

Market Talk
Tulu

Firefly Aerospace Sets Plan for Next Launch After Explosion -- Market Talk

DJ

Loe

12. nov 2025, 22:18 UTC

Tulu

Cisco Systems Boosts Outlook on AI-Driven Demand -- Update

DJ

Loe

12. nov 2025, 22:12 UTC

Market Talk

Bank of Canada Rate Hikes Could Start in 2H 2026 -- Market Talk

DJ

Loe

12. nov 2025, 22:05 UTC

Tulu

Pan American Silver: Campbell Succeeded Steve Busby >PAAS

DJ

Loe

12. nov 2025, 22:04 UTC

Tulu

Pan American Silver Named Scott Campbell as Operating Chief on Oct. 20

DJ

Loe

12. nov 2025, 22:04 UTC

Tulu

Pan American Silver 3Q Adj EPS 48c >PAAS

DJ

Loe

12. nov 2025, 22:04 UTC

Tulu

Pan American Silver 3Q Rev $884.4M >PAAS

DJ

Loe

12. nov 2025, 22:04 UTC

Tulu

Pan American Silver 3Q EPS 45c >PAAS

DJ

Loe

12. nov 2025, 22:03 UTC

Tulu

Manulife Financial: 3Q Book Value Per Common Shr C$26.07 >MFC.T

DJ

Loe

12. nov 2025, 22:02 UTC

Tulu

Manulife Financial 3Q Net C$1.8B >MFC

DJ

Loe

12. nov 2025, 22:02 UTC

Tulu

Manulife Financial 3Q Adj EPS C$1.16 >MFC

DJ

Loe

12. nov 2025, 22:02 UTC

Tulu

Manulife Financial 3Q EPS C$1.02 >MFC

DJ

Loe

12. nov 2025, 21:53 UTC

Omandamised, ülevõtmised, äriostud

BlueScope Steel: Sale Strengthens Focus on Own Growth Investments

DJ

Loe

12. nov 2025, 21:53 UTC

Omandamised, ülevõtmised, äriostud

BlueScope Steel Says Deal Subject to Indian Regulatory Approvals

DJ

Loe

12. nov 2025, 21:53 UTC

Omandamised, ülevõtmised, äriostud

BlueScope Steel Estimates Net Profit After Tax on Sale of A$70 Million

DJ

Loe

12. nov 2025, 21:53 UTC

Omandamised, ülevõtmised, äriostud

BlueScope Steel Expects Net Proceeds After Taxes, Fees of A$179 Million in 2H FY26

DJ

Loe

12. nov 2025, 21:52 UTC

Omandamised, ülevõtmised, äriostud

BlueScope Steel: Tata BlueScope Steel JV a Provider of Coated, Painted Steel Products in India

DJ

Loe

12. nov 2025, 21:51 UTC

Omandamised, ülevõtmised, äriostud

BlueScope Steel Agrees to Sell 50% Stake in Tata BlueScope Steel Joint Venture to Tata Steel

DJ

Loe

12. nov 2025, 21:50 UTC

Market Talk
Tulu

Basic Materials Roundup: Market Talk

DJ

Loe

12. nov 2025, 21:49 UTC

Tulu

Cisco Stock Climbs as Earnings Beat Expectations Amid Strong AI Demand -- Barrons.com

DJ

Loe

12. nov 2025, 21:48 UTC

Tulu

If Investors Like Rocket Lab Stock, They Should Love Firefly Shares. -- Barrons.com

DJ

Loe

12. nov 2025, 21:40 UTC

Tulu

Xero Beats 1H Profit Expectations Despite Melio Margin Hit

DJ

Loe

Võrdlus sarnastega

Hinnamuutus

Pulse Biosciences Inc Prognoos

Hinnasiht

By TipRanks

46.67% tõus

12 kuu keskmine prognoos

Keskmine 22 USD  46.67%

Kõrge 22 USD

Madal 22 USD

Põhineb 1 Wall Streeti analüütiku instrumendi Pulse Biosciences Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

1 ratings

1

Osta

0

Hoia

0

Müü

Põhineb 1 analüütiku instrumendi Pulse Biosciences Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

16.59 / 17.17Toetus ja vastupanu

Lühikene perspektiiv

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Keskpikk perspektiiv

Bearish Evidence

Recent bearish events outweigh bullish events.

Pikk perspektiiv

Weak Bearish Evidence

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

333 / 374 Pingereas Tervishoid

Uudiste sentiment

Tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

Muud aktsiad sektorist

LLY

Eli Lilly and Co.

1,017.74

↑ +3%

JNJ

Johnson and Johnson

194.37

↑ +0.29%

ABBV

AbbVie Inc

233.26

↑ +3.63%

UNH

UnitedHealth Group Inc

339.07

↑ +3.56%

AZN

AstraZeneca PLC ADR

87.67

↓-1.55%
help-icon Live chat